Eventide Asset Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-225,000	Closed	-$2.95M	–	125
2016 Q4	$2.95M	Buy	+225,000	New	+$2.95M	0.19%	85